The novel inflammatory marker GlycA and the prevalence and progression of valvular and thoracic aortic calcification: The Multi-Ethnic Study of Atherosclerosis

GlycA is a novel composite biomarker of systemic inflammation reflecting posttranslational glycosylation of acute phase reactants. GlycA has been associated with coronary artery calcium, cardiovascular disease (CVD) events and mortality. Vascular calcifications outside of the coronary arteries are risk markers of CVD and mortality. Whether GlycA is linked to extra-coronary calcifications (ECC) is not well established.

Source: Atherosclerosis - January 24, 2019 Category: Cardiology Authors: Angelica Ezeigwe, Oluwaseun E. Fashanu, Di Zhao, Matthew J. Budoff, James D. Otvos, Isac C. Thomas, Samia Mora, Martin Tibuakuu, Erin D. Michos Source Type: research